天然稳定钙同位素比值是慢性肾脏病骨钙平衡的新型生物标志物
研究在42例慢性肾脏病儿童和92例透析患者中测定血清44/42Ca比值,并与骨生物标志物及双能X线吸收法和外周定量CT骨密度比较。该比值与骨形成标志物正相关、与骨吸收标志物负相关,且与骨密度z评分正相关,重复测定高度相关。
要点
- 44/42Ca血清比值与血清钙、25-羟基维生素D、碱性磷酸酶正相关,与甲状旁腺激素及骨吸收标志物负相关。
- 44/42Ca血清比值与胫骨小梁骨密度、总骨矿物质含量及髋部骨密度的年龄校正z评分正相关。
- 透析患者44/42Ca血清比值较年龄匹配儿童低157%、较骨质疏松老年女性低29%,提示骨矿物质含量显著更低。
核心结论
- 钙同位素比值可能为评估慢性肾脏病骨钙平衡提供一种新型、敏感且无创的方法。
研究设计与样本
- 研究纳入42例慢性肾脏病儿童和92例接受透析治疗的患者,采用电感耦合等离子体质谱法测定血液、尿液和粪便中的钙同位素。
主要发现
- 44/42Ca血清比值与血清钙、25-羟基维生素D和碱性磷酸酶正相关,与血清甲状旁腺激素及其他骨吸收标志物负相关。
- 44/42Ca血清比值与外周定量CT测得的胫骨小梁骨密度和总骨矿物质含量的年龄校正z评分正相关,与双能X线吸收法测得的髋部骨密度正相关。
- 总骨矿物质含量的显著独立预测因素为44/42Ca血清比值和甲状旁腺激素。
- 44/42Ca血清比值在四周后重复测定与基线值高度相关。
- 校正含钙药物和肾功能损害后,透析患者的44/42Ca血清比值较年龄匹配儿童低157%,较骨质疏松老年女性低29%。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Dysregulated calcium homeostasis is common in chronic kidney disease and causally associated with disorders of bone mineralization. However, radiological measures and biomarkers do not allow accurate evaluation of bone calcium balance. Non-radioactive calcium isotopes, 42Ca and 44Ca, are present in our diet and sequestered into body compartments following principles of kinetic isotope fractionation. Isotopically light 42Ca is preferentially incorporated into bone, while heavier 44Ca is excreted. The ratio (44/42Caserum) increases when bone formation exceeds resorption and vice versa, reflecting bone calcium balance. We measured these calcium isotopes by inductively coupled plasma mass-spectrometry in blood, urine and feces of 42 children with chronic kidney disease and 92 receiving dialysis therapy. We compared the isotope ratios with bone biomarkers and determined total bone mineral content by dual-energy x-ray absorptiometry and peripheral quantitative CT expressed as age-adjusted z-scores. The 44/42Caserum ratio positively correlated with serum calcium, 25-hydroxyvitamin D and alkaline phosphatases and inversely with serum parathyroid hormone and other bone resorption markers. The 44/42Caserum ratio positively correlated with age-adjusted z-scores of tibial trabecular bone mineral density and total bone mineral content measured by peripheral quantitative CT, and hip bone mineral density measured by dual-energy X-ray absorptiometry. Significant and independent predictors of total bone mineral content, measured by, were the 44/42Caserum ratio and parathyroid hormone. The 44/42Caserum ratio, repeated after four weeks, highly correlated with baseline values. When adjusted for calcium-containing medications and kidney impairment, the 44/42Caserum ratio in patients receiving dialysis was 157% lower than that of age-matched children and 29% lower than levels in elderly women with osteoporosis, implying significantly lower bone mineral content. Thus, calcium isotope ratios may provide a novel, sensitive and non-invasive method of assessing bone calcium balance in chronic kidney disease.
引用
- Shroff R, Lalayiannis AD, Fewtrell M, et al. Naturally occurring stable calcium isotope ratios are a novel biomarker of bone calcium balance in chronic kidney disease. Kidney Int. 2022. PMID: 35644284. doi:10.1016/j.kint.2022.04.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。